NCM
PVLA

Nantahala Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Nantahala Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250,062
Closed -$15.7M – 182
2025
Q3 		$15.7M Hold
250,062
– – 0.97% 44
2025
Q2 		$5.64M Hold
250,062
– – 0.4% 88
2025
Q1 		$7M Hold
250,062
– – 0.58% 56
2024
Q4 		$3M Buy
+250,062
New +$3.93M 0.21% 100
2019
Q3 		– Sell
-18,470
Closed -$6.95M – 107
2019
Q2 		$6.95M Buy
18,470
+1,494
+9% +$446K 0.41% 65
2019
Q1 		$4.55M Hold
16,976
– – 0.3% 74
2018
Q4 		$3.61M Buy
16,976
+9,028
+114% +$2.8M 0.27% 84
2018
Q3 		$3.56M Buy
+7,948
New +$3.45M 0.24% 82

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $2.16B AUM 162.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return